Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.jviromet.2021.114178 http://scihub22266oqcxt.onion/10.1016/j.jviromet.2021.114178 33961910!8095018!33961910     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       J+Virol+Methods 2021 ; 294 (ä): 114178 Nephropedia Template TP {{tp|p=33961910|t=2021. Performance evaluation of the Simtomax(R) CoronaCheck rapid diagnostic test |pdf=|usr=}}{{33961910}} gab.com Text Performance evaluation of the Simtomax(R) CoronaCheck rapid diagnostic test JO: J Virol Methods http://www.kidney.de/pget.php?&tw=1&pmid=33961910 #FOAvip The aim of this study was to evaluate the diagnostic performance of Simtomax(R) CoronaCheck, a serology rapid diagnostic test (RDT) for the detection of IgG and IgM against SARS-CoV-2. 48 plasma samples positive for SARS-CoV-2 based on RT-PCR and 98 negative control samples were studied. Diagnostic performance of the IgG/IgM RDT was assessed against RT-PCR and the electro-chemiluminescence immunoassay (ECLIA) Elecsys(R) Anti-SARS-CoV-2 total Ig. Overall, the RDT sensitivity was 92 % (95 % confidence interval [95 %CI]: 79-97), specificity 97 % (95 % CI: 91-99 %), PPV 94 % (95 % CI: 81-98) and the NPV 96 % (95 % CI: 89-99). When considering only samples collected >/= 15 days post-symptoms (DPS), the sensitivity increased to 98 % (95 %CI: 86-100) and the specificity was 97 % (95 % CI: 91-99 %). Two samples with 180 DPS were still positive for IgG. Globally, this IgG/IgM RDT displayed a high diagnostic accuracy for SARS-CoV-2 IgG/IgM detection in plasma samples in high COVID-19 prevalence settings. It could be effectively used, in absence of facilities for routine diagnostic serology, for samples with a DPS between 15 and 180 days. Twit Text FOAVip Performance evaluation of the Simtomax(R) CoronaCheck rapid diagnostic test ????J Virol Methods http://www.kidney.de/pget.php?&tw=1&pmid=33961910 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33961910 #FOAvip English Wikipedia <ref>{{Cite pmid|33961910}}</ref> Performance evaluation of the Simtomax(R) CoronaCheck rapid diagnostic test #MMPMID33961910 Ducrest PJ; Freymond A; Segura JM J Virol Methods 2021[Aug]; 294 (ä): 114178 PMID33961910show ga The aim of this study was to evaluate the diagnostic performance of Simtomax(R) CoronaCheck, a serology rapid diagnostic test (RDT) for the detection of IgG and IgM against SARS-CoV-2. 48 plasma samples positive for SARS-CoV-2 based on RT-PCR and 98 negative control samples were studied. Diagnostic performance of the IgG/IgM RDT was assessed against RT-PCR and the electro-chemiluminescence immunoassay (ECLIA) Elecsys(R) Anti-SARS-CoV-2 total Ig. Overall, the RDT sensitivity was 92 % (95 % confidence interval [95 %CI]: 79-97), specificity 97 % (95 % CI: 91-99 %), PPV 94 % (95 % CI: 81-98) and the NPV 96 % (95 % CI: 89-99). When considering only samples collected >/= 15 days post-symptoms (DPS), the sensitivity increased to 98 % (95 %CI: 86-100) and the specificity was 97 % (95 % CI: 91-99 %). Two samples with 180 DPS were still positive for IgG. Globally, this IgG/IgM RDT displayed a high diagnostic accuracy for SARS-CoV-2 IgG/IgM detection in plasma samples in high COVID-19 prevalence settings. It could be effectively used, in absence of facilities for routine diagnostic serology, for samples with a DPS between 15 and 180 days. |Adolescent[MESH] |Adult[MESH] |Antibodies, Viral/*blood[MESH] |COVID-19 Serological Testing/methods/*standards[MESH] |COVID-19/*diagnosis/immunology[MESH] |Female[MESH] |Humans[MESH] |Immunoassay/methods/*standards[MESH] |Immunoglobulin G/blood[MESH] |Immunoglobulin M/blood[MESH] |Male[MESH] |Middle Aged[MESH] |Reagent Kits, Diagnostic/*standards[MESH] |SARS-CoV-2/immunology[MESH] |Sensitivity and Specificity[MESH]Performance evaluation of the Simtomax(R) CoronaCheck rapid diagnostic(epmc).pdf DeepDyve Pubget Overpricing